Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Faculty Opinions recommendation of Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease. — Ralf Weiskirchen | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
RW
Shared by
Ralf Weiskirchen
Faculty Opinions recommendation of Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
Dataset
en
Authors
RW
Ralf Weiskirchen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.
Ralf Weiskirchen
DOI
10.3410/f.726024962.793514854
Year
Published
—
Language
en
Dataset Details
Link Of The Paper
https://doi.org/10.3410/f.726024962.793514854
Timeline
Created:
June 19, 2026
Dataset
Faculty Opinions recommendation of The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.